We are building an AI Platform that helps organizations measure and reduce their carbon footprint. Our solutions help turn consumption and emissions data into action, enabling real and significant progress toward a lower organizational footprint. We are backed by the Rice Investment Group and Carnrite Ventures and are currently in initial development stages.

Founded in 2010, Pinnacle Transplant Technologies recognized the need to establish a processing and distribution facility that would enable medical professionals to acquire safe quality allograft tissue for transplant. The company manufactures innovative allografts produced to the highest standards of quality and safety. With a dedication to customer service, we are devoted to being the most responsive and accommodating Tissue Bank in the industry. Learn more about our specific products. Pinnacle is a multi-service tissue bank dedicated to the ethical participation in the Donate Lifeâ„¢ process. U.S. Food and Drug Administration (FDA) registered and American Association of Tissue Banks (AATB) accredited, Pinnacle only works with federally chartered Organ Procurement Organizations (OPOs) and agencies accredited by AATB to help provide superior allografts for transplantation, assure transplant patient safety, safeguard our associates, and assure reverence to our donor families.